Milestone agreement for the lease of SkyCell’s hybrid pharma containers • Containers maintain constant temperatures for more than a week • Suitable for all Covid-19 vaccines on the market
DB Schenker increases response to the pandemic by signing a Master Lease Agreement (MLA) with SkyCell. The partnership enables DB Schenker to enhance its vaccine logistics service solutions with additional flexibility through the new healthcare product DB SCHENKERlife+. Based in Switzerland, SkyCell …

The post DB Schenker partners with SkyCell on temperature-regulated containers for Covid vaccines appeared first on The Loadstar.

Source: The Loadstar